Oguzhan Atay

Oguzhan Atay is the Co-founder & CEO of BillionToOne, a precision diagnostics company that quantifies biology to create powerful molecular diagnostics. BillionToOne work to improve disease detection by counting molecules with their proprietary molecular counting platform, placing patients at the forefront of everything they do. The company is currently applying their proprietary technology to non-invasive prenatal screening and liquid biopsy.

Oguzhan holds a Ph.D. from Stanford in Systems Biology, where he implemented machine learning algorithms and mathematical models to solve specific problems in cellular biology and developed a data-driven mathematical framework to simplify the analysis of complex biological networks. He also has a degree in Molecular Biology from Princeton, as well as minors in Computer Science, Physics, and Applied Mathematics.